Bank of Baroda faces a $15 billion lawsuit from NMC Healthcare founder Bavaguthu Raghuram Shetty, after the bank settled a related case for ₹5,700 crore (US$600 m) in June 2026—an amount that, according to the complaint, is many times the loss the bank reported to regulators.
The suit accuses the bank of facilitating fraud by enabling fund diversion, ignoring anti‑money‑laundering alerts, and accepting forged guarantees. Shetty seeks ₹5,000 cr in direct damages, another ₹5,000 cr in consequential losses, and ₹5,000 cr for reputational harm, plus 18% per annum interest on the first two claims from the filing date.
In June 2026 Bank of Baroda agreed to pay the ₹5,700 cr settlement under SEBI Regulation 30, but the payment was made without admission of liability. The settlement was disclosed on July 2, 2026, and the complaint argues it does not reduce Shetty’s separate claims, which remain pending.
The bank’s 2025 annual report failed to disclose these claims as contingent liabilities, a fact highlighted by the suit. Regulatory scrutiny is likely to intensify as the case moves forward, potentially impacting the bank’s risk‑adjusted return on capital.
Market observers note that banking sector compliance failures have already pressured peers; a $15 billion exposure could erode investor confidence and trigger margin calls for BOB’s senior management.
The court is expected to schedule hearings in the coming months, and the bank has not issued guidance on the potential financial impact. Analysts will watch the proceedings closely for indications of how the lawsuit might affect BOB’s balance sheet and regulatory standing.